UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evolution of platelets in chronic hepatitis C infected patients and advanced liver fibrosis after direct-acting antiviral treatment

Journal of hepatology, 2017, Vol.66 (1), p.S311-S312

2017

Volltextzugriff (PDF)

Protective effect of quercetin treatment on HFD-induced intestinal dysbiosis and barrier dysfunction in an in vivo model of non-alcoholic fatty liver disease

Journal of hepatology, 2017, Vol.66 (1), p.S169-S169

2017

Volltextzugriff (PDF)

Changes in the lipid profile in hepatitis C virus infected patients treated with direct-acting antivirals

Journal of hepatology, 2017, Vol.66 (1), p.S729-S729

2017

Volltextzugriff (PDF)

The role of dysbiosis in the development of non-alcoholic fatty liver disease in obese patients

Journal of hepatology, 2017, Vol.66 (1), p.S156-S156

2017

Volltextzugriff (PDF)

Adherence to SmPC recommendations in real-world practice in the treatment of monoinfected patients with chronic genotype 1 or 4 HCV infection with direct-acting antivirals

Journal of hepatology, 2017, Vol.66 (1), p.S522-S523

2017

Volltextzugriff (PDF)

Effectiveness of ribavirin use associated with direct-acting antivirals in the treatment of non-cirrhotic patients with genotype 1a or 4 HCV infection in real-world practice

Journal of hepatology, 2017, Vol.66 (1), p.S523-S524

2017

Volltextzugriff (PDF)

High Efficacy of Interferon-Free Treatments in Real-World Patients with Chronic Hepatitis C a Multicentric Study

Journal of hepatology, 2016, Vol.64 (2), p.S764-S765

2016

Volltextzugriff (PDF)

Efficacy of Interferon-Free Therapy in Cirrhotic and Non-Cirrhotic Chronic Hepatitis C Patients in Clinical Practice

Journal of hepatology, 2016, Vol.64 (2), p.S765-S765

2016

Volltextzugriff (PDF)

Simeprevir and Sofosbuvir with or without Ribavirin in Genotype 1 Chronic Hepatitis C Patients: Efficacy and Safety in Real Life

Journal of hepatology, 2016, Vol.64 (2), p.S765-S766

2016

Volltextzugriff (PDF)

P1041 TENOFOVIR MONOTHERAPY VERSUS LAMIVUDINE PLUS ADEFOVIR IN LAMIVUDINE-FAILURE PATIENTS RESCUED WITH LAMIVUDINE PLUS ADEFOVIR COMBINATION: INTERIM ANALYSIS OF THE TENOSIMP-B CLINICAL TRIAL

Journal of hepatology, 2014-04, Vol.60 (1), p.S422-S422

2014

Volltextzugriff (PDF)

P1178 TELAPREVIR-BASED TRIPLE THERAPY IN PATIENTS WITH MODERATE FIBROSIS. SPANISH MULTICENTRE STUDY IN CLINICAL PRACTICE

Journal of hepatology, 2014-04, Vol.60 (1), p.S478-S478

2014

Volltextzugriff (PDF)

868 LIVER X RECEPTOR a-MEDIATED LIPOGENESIS INDUCED BY HEPATITIS C VIRUS NS5A AND CORE PROTEINS REGULATES VIRAL REPLICATION IN AN IN VITRO MODEL

Journal of hepatology, 2012-04, Vol.56, p.S338-S338

2012

Volltextzugriff (PDF)

P1198 EFFECTIVENESS OF TRIPLE THERAPY IN CLINICAL PRACTICE FOR TREATMENT-NAIVE HCV PATIENTS WITH ADVANCED HEPATIC FIBROSIS. VIROLOGIC RESPONSE DATA AT 12 WEEKS POST-TREATMENT (SVR-12W)

Journal of hepatology, 2014-04, Vol.60 (1), p.S486-S487

2014

Volltextzugriff (PDF)

1109 HIGH VS STANDARD DOSE OF RIBAVIRIN PLUS PEGINTERFERON-ALFA-2A IN CHRONIC HEPATITIS C, GENOTYPE 3 AND HIGH VIRAL LOAD. FINAL RESULTS OF THE DARGEN-3 STUDY

Journal of hepatology, 2012-04, Vol.56, p.S437-S437

2012

Volltextzugriff (PDF)

804 EFFECT OF HCV NS5A AND CORE PROTEINS AND VIRAL REPLICATION ON LXRa-MEDIATED LIPOGENIC GENES INDUCTION IN AN IN VITRO MODEL

Journal of hepatology, 2011-03, Vol.54, p.S323-S323

2011

Volltextzugriff (PDF)

1097 CARDIOTROPHIN-1 DEFENDS AGAINST VIRAL-INDUCED LETHAL ACUTE LIVER FAILURE (ALF) OF RABBITS BY ATTENUATING LIVER INFLAMMATION AND INDUCING CYTOPROTECTIVE GROWTH FACTORS

Journal of hepatology, 2011-03, Vol.54, p.S434-S434

2011

Volltextzugriff (PDF)

171 MAP KINASE-DEPENDENT PATHWAYS ARE ACTIVATED DURING PROGRAMMED CELL DEATH IN A VIRAL MODEL OF FULMINANT HEPATIC FAILURE

Journal of hepatology, 2008, Vol.48, p.S73-S73

2008

Volltextzugriff (PDF)

Sensitivity of breasts reconstructed with the autologous latissimus dorsi flap

Plastic and reconstructive surgery (1963), 2000-08, Vol.106 (2), p.302-309

2000

Volltextzugriff (PDF)

1001 INTERIM ANALYSIS FROM TRIC-1 A STUDY OF METFORMIN WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT NAIVE GENOTYPE 1 CHRONIC HEPATITIS C WITH INSULIN RESISTANCE

Journal of hepatology, 2008, Vol.48, p.S375-S375

2008

Volltextzugriff (PDF)

Impairment of metabolic function in chronic hepatitis C is related to factors associated with resistance to therapy

The American journal of gastroenterology, 2001, Vol.96 (8), p.2456-2461

2001

Volltextzugriff (PDF)

Endoscopic ultrasonography in the diagnosis of aortoesophageal fistula

The American journal of gastroenterology, 2000, Vol.95 (5), p.1374-1375

2000

Volltextzugriff (PDF)

Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349]

Gastroenterología y hepatología, 2018-08, Vol.41 (7), p.475-476

2018

Volltextzugriff (PDF)

Tumor de Frantz o neoplasia sólida seudopapilar de páncreas

Gastroenterología y hepatología, 2015-08, Vol.38 (7), p.468-470

2015

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieRevista De Gastroenterología De México

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(70)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evolution of platelets in chronic hepatitis C infected patients and advanced liver fibrosis after direct-acting antiviral treatment

Protective effect of quercetin treatment on HFD-induced intestinal dysbiosis and barrier dysfunction in an in vivo model of non-alcoholic fatty liver disease

Changes in the lipid profile in hepatitis C virus infected patients treated with direct-acting antivirals

The role of dysbiosis in the development of non-alcoholic fatty liver disease in obese patients

Adherence to SmPC recommendations in real-world practice in the treatment of monoinfected patients with chronic genotype 1 or 4 HCV infection with direct-acting antivirals

Effectiveness of ribavirin use associated with direct-acting antivirals in the treatment of non-cirrhotic patients with genotype 1a or 4 HCV infection in real-world practice

High Efficacy of Interferon-Free Treatments in Real-World Patients with Chronic Hepatitis C a Multicentric Study

Efficacy of Interferon-Free Therapy in Cirrhotic and Non-Cirrhotic Chronic Hepatitis C Patients in Clinical Practice

Simeprevir and Sofosbuvir with or without Ribavirin in Genotype 1 Chronic Hepatitis C Patients: Efficacy and Safety in Real Life

Effectiveness and Safety of Ombitasvir, Paritaprevir, Ritonavir and Dasabuvir Patients with Genotype 1 Chronic Hepatitis C Virus Infection: Results from the Spanish Real World Cohort

Effectiveness and Safety of Sofosbuvir/Ledipasvir Treatment for Monoinfected Genotype 1 HCV Patients in Real-Life Clinical Practice: Results from Spanish Hepa-C Cohort

P1041 TENOFOVIR MONOTHERAPY VERSUS LAMIVUDINE PLUS ADEFOVIR IN LAMIVUDINE-FAILURE PATIENTS RESCUED WITH LAMIVUDINE PLUS ADEFOVIR COMBINATION: INTERIM ANALYSIS OF THE TENOSIMP-B CLINICAL TRIAL

P1178 TELAPREVIR-BASED TRIPLE THERAPY IN PATIENTS WITH MODERATE FIBROSIS. SPANISH MULTICENTRE STUDY IN CLINICAL PRACTICE

868 LIVER X RECEPTOR a-MEDIATED LIPOGENESIS INDUCED BY HEPATITIS C VIRUS NS5A AND CORE PROTEINS REGULATES VIRAL REPLICATION IN AN IN VITRO MODEL

P1198 EFFECTIVENESS OF TRIPLE THERAPY IN CLINICAL PRACTICE FOR TREATMENT-NAIVE HCV PATIENTS WITH ADVANCED HEPATIC FIBROSIS. VIROLOGIC RESPONSE DATA AT 12 WEEKS POST-TREATMENT (SVR-12W)

1109 HIGH VS STANDARD DOSE OF RIBAVIRIN PLUS PEGINTERFERON-ALFA-2A IN CHRONIC HEPATITIS C, GENOTYPE 3 AND HIGH VIRAL LOAD. FINAL RESULTS OF THE DARGEN-3 STUDY

804 EFFECT OF HCV NS5A AND CORE PROTEINS AND VIRAL REPLICATION ON LXRa-MEDIATED LIPOGENIC GENES INDUCTION IN AN IN VITRO MODEL

1097 CARDIOTROPHIN-1 DEFENDS AGAINST VIRAL-INDUCED LETHAL ACUTE LIVER FAILURE (ALF) OF RABBITS BY ATTENUATING LIVER INFLAMMATION AND INDUCING CYTOPROTECTIVE GROWTH FACTORS

171 MAP KINASE-DEPENDENT PATHWAYS ARE ACTIVATED DURING PROGRAMMED CELL DEATH IN A VIRAL MODEL OF FULMINANT HEPATIC FAILURE

Sensitivity of breasts reconstructed with the autologous latissimus dorsi flap

1001 INTERIM ANALYSIS FROM TRIC-1 A STUDY OF METFORMIN WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT NAIVE GENOTYPE 1 CHRONIC HEPATITIS C WITH INSULIN RESISTANCE

Impairment of metabolic function in chronic hepatitis C is related to factors associated with resistance to therapy

Endoscopic ultrasonography in the diagnosis of aortoesophageal fistula

Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349]

Tumor de Frantz o neoplasia sólida seudopapilar de páncreas

Aktive Filter

Suchergebnisse filtern